Meeting
2020 Gastrointestinal Cancers Symposium
A phase II study of neoadjuvant chemotherapy with DCS for resectable advanced esophageal cancer.
Authors
Junya Kitadani
Second Department of Surgery, Wakayama Medical University, School of Medicine, Wakayama, Japan
Junya Kitadani , Masaki Nakamura , Toshiyasu Ojima , Masahiro Katsuda , Keiji Hayata , Hiroki Yamaue
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
UMIN000017153
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 366)
Abstract #
366
Poster Bd #
D21
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204).
First Author: Izuma Nakayama
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
First Author: Yuri Yoshinami
Poster
2022 ASCO Annual Meeting
Phase 3 randomized study comparing docetaxel-platinum with docetaxel-platinum-5 fluorouracil as neoadjuvant chemotherapy in technically unresectable oral cancer.
First Author: Ajaykumar Singh
Poster
2022 ASCO Annual Meeting
Phase II trial of perioperative chemotherapy of esophageal cancer: PIECE trial.
First Author: Motoo Nomura